GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer

Lifang Cheng(University of North Carolina at Chapel Hill), Jian Zhang(Zhujiang Hospital)
International Journal of Oncology
June 22, 2020
Cited by 44


Related Papers